期刊文献+

阿卡波糖合用荷丹片改善老年餐后高血糖和胰岛素敏感性的临床观察 被引量:2

Clinical Observation on Improving Senile Postprandial Hyperglycemia and Insulin Sensitivity with Combination of Acarbose and hedan table
原文传递
导出
摘要 目的:观察阿卡波糖合用荷丹片降低餐后血糖、改善胰岛素敏感性的作用。方法:选择106例单纯餐后高血糖的老年患者,分为单用阿卡波糖组(对照组)53例,和荷丹片合用阿卡波糖组(观察组)53例,治疗2个月后分别观察两组的餐后血糖(2 h PG)、血脂、体重指数、以及胰岛素抵抗指数和不良反应等指标的变化。结果:观察组2 h PG、BM I、胆固醇(CH)和低密度脂蛋白(LDL-C)、甘油三脂(TG)较对照组改善明显(P<0.05)。胰岛素抵指数两组均有明显改善(P<0.05),且观察组与对照组比较差异有显著性(P<0.01)。观察组不良反应明显比对照组减少。结论:阿卡波糖与荷丹片合用,不仅可改善餐后高血糖状态,而且明显增强胰岛素敏感性,对血脂、体重指数等也有明显的改善作用,两药合用后,阿卡波糖的不良反应明显减少。 Objective:To observe the effect of combination therapy of acarbose and hedan table in improving senile postprandial hyperglycemia and insulin sensitivity. Methods :106 patients with simple postprandial hyperglycemia were divided into the control group and the treated group,53 in each group,who were treated with acarbose alone and the combination therapy respectively for 2 months, and the changes on 2 hrs postprandial glucose (2hPG), blood lipid, body mass index (BMI) ,insulin functional index as well as the adverse reaction of acarbose in the two groups were observed. Results : After treatment, the levels of 2 hPG, BMI, total cholesterol and lowdensity lipoprotein - cholesterol, Triglyceride (TG) were inproved in the treated groups more significantly than those in the control group (P 〈0. 01 ). Insulin resistance were improved in the two group (P 〈0. 05). Moreover,the adverse reactions were less in the treated group than in the control group. Conclusion:The combination therapy of acarbose and Hedan Table could not only improve the postprandial hyperglycemia, but also markedly increase the insulin sensitivity, and shows obvious improving effect on parameters of blood lipid, BMI. The adverse reaction coule be evidently reduced, by combined use with hedan table.
作者 叶世伟
出处 《中华中医药学刊》 CAS 2009年第8期1791-1792,共2页 Chinese Archives of Traditional Chinese Medicine
关键词 阿卡波糖 荷丹片 餐后高血糖 胰岛素敏感性 acarbose hedan table postprandial hyperglycemia insulin sensitivity
  • 相关文献

参考文献5

  • 1STOP - NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP - NIDDM randomized trial [ J ]. Lancet,2002,359 (9323) :2072 - 2077.
  • 2Salman S,Salman f, Satman I,et al. Comparison of acarbose and gliclazide as first - line agents in patients with type 2 diabetes [J]. Curr Med Res Opin,2001,16(4) :296 -306.
  • 3郑粤文,李敏,黄惠娟.中药治疗餐后高血糖临床观察[J].吉林中医药,2007,27(7):16-17. 被引量:2
  • 4杨浔光,周鑫根,胡祥林,焦蓉蓉.荷丹片与辛伐他汀治疗高脂血症的临床观察[J].实用临床医学(江西),2005,6(9):55-55. 被引量:10
  • 5Abbink E J, Pickkers P, Van Rosedaal A J, et al. Vascular K (ATP) channel blockade by glibenclamide,but not by acarbose, in patients with type 2 diabetes[ J]. Clin Sci (London) ,2002, 102(3) :307 -314.

二级参考文献10

  • 1Tveasure CB,Kiein JL,Weintraub WS,et al.Benefical effects of cholestero-llowering therapy on the coronary end-theium in patients with coronary disease[J].N Engl J Med,1995,332(9):481~487.
  • 2Shephered,Cobbe SM,Forod I,et al.Prerention of coronary heart disease with prarasfion in men with hyperchol esterolemia[J].N Engl J Med,1995,333(10):1 301~1 307.
  • 3陆宗良.血脂康调整血脂对冠心病二级预防的研究[N].中国医学论坛报,2004-07-30(27).
  • 4Edelstein SL,Knowler WC,Bain RP,et al.Predictors of progression from impaired glucose tolerance to NIDDM:an analysis of six prospective studies.Diabetes,1997,46(5):701-710.
  • 5Chou p,Li WU,Wu GS,et al.Progression to diabetes among high-risk groups in Kin-Chen,Kinmen:Exploring the natural history of type 2 diabetes.Diabetes Care,1998,(7):1183-1187.
  • 6Knower WC,Narayan KMV,Zimmet P.Preventing non-insulindependent diabetes.Diabetes,1995,(4):483-488.
  • 7Pan Xiaoren,et al.Chin J Intern Med.1995,(34):108-112.
  • 8全国糖尿病防治协作组,潘孝仁,杨文英,刘娟,郑旭,王芃,刘铨之.1994年中国糖尿病患病率及其危险因素[J].中华内科杂志,1997,36(6):384-389. 被引量:430
  • 9王克安,李天麟,向红丁,刘尊永,白锦,冯晋光,富振英,马林茂,陈君石,金书香,李彦琴,秦汝莉,陈泓,孙天剑,满青青.中国糖尿病流行特点研究 糖尿病和糖耐量低减患病率调查[J].中华流行病学杂志,1998,19(5):282-285. 被引量:460
  • 10陆宗良,顼志敏.血脂异常的治疗 第10讲 调脂治疗中的几个热点问题[J].中国医刊,2002,37(2):41-44. 被引量:12

共引文献10

同被引文献30

  • 1党美林,张华其,王敏红.拜糖苹治疗餐后高血糖的临床观察[J].延安大学学报(医学科学版),2006,4(2):63-63. 被引量:1
  • 2陆宗良.糖尿病患者血脂异常的治疗[J].中国糖尿病杂志,2007,15(1):2-4. 被引量:41
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5227
  • 4郑粤文,李敏,黄惠娟.中药治疗餐后高血糖临床观察[J].吉林中医药,2007,27(7):16-17. 被引量:2
  • 5Nielson C, Lange T, Hadjokas N. Blood glucose and coronary artery disease in nondiabetic patients [ J ]. Diabetes Care, 2006, 29 ( 5 ) : 998 - 1001.
  • 6American Diabetes Association. Standards of Medical Care in Diabetes - 2013[J]. Diabetes Care, 2013, 36(sl ):11 -66.
  • 7Joel C M. Glucose and Low - Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes : Focus on Combination Therapy with Colesevelam HCI[J]. Drugs Aging, 2012, 29(5) : el -el2.
  • 8Kashyap S, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes [ J ]. Diabetes, 2003, 52(10) : 2461 - 2474.
  • 9Raabe M, Veniant MM,Sulljvan MA,^al. Analysis of the role ofmicrosomal triglyceride transfer protein in the liver of tissue spe-cific knock - out mice[J]. Chin Invest,1999,103(9) : 1287 - 1298.
  • 10Aspichveta P, Perez - Agote B, Perez S,et al. Impaired responseof VLDL Lipid and Apo B Secretion to endotoxin in the fasted ratliver[J]. Endotoxin Rds,2006,12(3) : 181 - 192.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部